Skip to content
AwardedUnited Kingdom£191,700

Oncotype DX Breast recurrence score test

Published
Published 24 October 2025
Deadline
Closed 30 June 2025

Overview

Breast Cancer Recurrence Score Test contract ref PTH-22-21-11621 Contract extension taken 1st July 2025

Key details

Country
United Kingdom
Status
Awarded
Estimated value
£191,700
Procedure
Selective
SME suitable
No
Published
24 October 2025
Deadline
Closed
Classification (CPV)
Blood-testing reagents

Award outcome

Awarded value
£191,700
Award date
19 October 2025
Contract period
30 June 2025 → 30 June 2026
Winner
  • Exact Sciences UK, Ltd.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    24 October 2025

Contracting authority

  • Leeds Teaching Hospital NHS Trust

    Buyer

    Leeds, United Kingdom

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Oncotype DX Breast recurrence score test — won by Exact Sciences UK, Ltd. — Skim